Search results
Older adults with aggressive blood cancer are responsive to treatment and show prolonged survival:...
Medical Xpress· 1 day agoStandard of care treatment for acute myeloid leukemia (AML) is safe and effective for adults over...
Exxon ordered to pay $725M to mechanic who claimed toxic chemicals caused his cancer
New York Post· 36 minutes agoThe 67-year-old former mechanic said in his 2020 lawsuit that he used petroleum products to clean...
Philadelphia jury awards former mechanic $725.5M in Exxon Mobil case
Philly.com· 5 hours agoA Philadelphia jury sided against Exxon Mobil Corp. and awarded $725.5 million on Thursday to a...
ExxonMobil Hit with $725M Verdict for Failure to Warn About Cancer-Causing Benzene in Gasoline
Morningstar· 5 hours agoA Philadelphia jury has returned a $725.5 million verdict against ExxonMobil, finding the company's failure to warn about known health risks of exposure to cancer-causing benzene in its petroleum ...
Researchers discover new target for potential leukemia therapy
Medical Xpress· 2 days agoThe study provides both mechanistic and preclinical evidence supporting the rapid initiation of...
CD7 expression tied to poorer outcomes with newly diagnosed leukemia
Medical Xpress· 6 days agoCD7 expression is associated with poorer outcomes in patients with newly diagnosed acute myeloid ...
GlycoMimetics reports Phase 3 trial of uproleselan falls short By Investing.com
Investing.com· 4 days agoThe study aimed to determine the efficacy of uproleselan in improving survival rates when used...
Phila. Jury Hits ExxonMobil With $725.5M Verdict Over Carcinogen in Gasoline | The Legal...
Law.com· 4 hours agoA Philadelphia state court jury hit ExxonMobil with a $725.5 million verdict Thursday for failing to...
Red carpet with a cause: This fashion show fundraiser helps kids with cancer
The Bergen Record via Yahoo News· 2 days agoIt is now a life purpose for Paula Corrieri, of Wayne, whose 15-year-old son, Rocco Sivolella, died...
GlycoMimetics downgraded after Phase 3 trial fails to meet endpoint By Investing.com
Investing.com· 3 days agoGlycoMimetics' uproleselan, a drug candidate for treating relapsed or refractory acute myeloid ...